Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Translational Andrology and Urology|May 9, 2024
Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime?Benjamin Lichtbroun, Saum Ghodoussipour, Vignesh T Packiam
European Urology|June 11, 2025
Re: Bladder-preserving Trimodality Treatment for High-grade T1 Bladder Cancer: Results from Phase II Protocol NRG Oncology/RTOG 0926Melinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam
Translational Andrology and Urology|January 18, 2021
The evolving role of lymphadenectomy for bladder cancer: why, when, and howVignesh T Packiam, Matvey Tsivian, Stephen A Boorjian
BJU International|April 8, 2026
Response to comment on 'Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer'Melinda Z Fu, Vignesh T Packiam, James Byrne
The Journal of Urology|April 9, 2026
Editorial CommentMelinda Z Fu, Vignesh T Packiam, Saum Ghodoussipour
European Urology Focus|March 27, 2019
Tumor Enucleation is Appropriate During Partial Nephrectomy: AgainstMatvey Tsivian, Vignesh T Packiam, R Houston Thompson
European Urology|October 17, 2025
The Future of Bladder Preservation for Muscle-invasive Bladder CancerMelinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam
The Journal of Urology|October 20, 2025
Editorial CommentMelinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam
European Urology|December 25, 2019
Microscopic Hematuria: Diagnosis Is Only Half the BattleVignesh T Packiam, Daniel A Barocas, Stephen A Boorjian
The Journal of Urology|December 3, 2024
Editorial CommentRachel Passarelli, Benjamin Lichtbroun, Saum Ghodoussipour, et al.
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Translational Andrology and Urology|May 9, 2024
Ablative therapy with UGN-102 for low-grade intermediate risk non-muscle-invasive bladder cancer: ready for primetime?Benjamin Lichtbroun, Saum Ghodoussipour, Vignesh T Packiam
European Urology|June 11, 2025
Re: Bladder-preserving Trimodality Treatment for High-grade T1 Bladder Cancer: Results from Phase II Protocol NRG Oncology/RTOG 0926Melinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam
Translational Andrology and Urology|January 18, 2021
The evolving role of lymphadenectomy for bladder cancer: why, when, and howVignesh T Packiam, Matvey Tsivian, Stephen A Boorjian
BJU International|April 8, 2026
Response to comment on 'Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer'Melinda Z Fu, Vignesh T Packiam, James Byrne
The Journal of Urology|April 9, 2026
Editorial CommentMelinda Z Fu, Vignesh T Packiam, Saum Ghodoussipour
European Urology Focus|March 27, 2019
Tumor Enucleation is Appropriate During Partial Nephrectomy: AgainstMatvey Tsivian, Vignesh T Packiam, R Houston Thompson
European Urology|October 17, 2025
The Future of Bladder Preservation for Muscle-invasive Bladder CancerMelinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam
The Journal of Urology|October 20, 2025
Editorial CommentMelinda Z Fu, Saum Ghodoussipour, Vignesh T Packiam
European Urology|December 25, 2019
Microscopic Hematuria: Diagnosis Is Only Half the BattleVignesh T Packiam, Daniel A Barocas, Stephen A Boorjian
The Journal of Urology|December 3, 2024
Editorial CommentRachel Passarelli, Benjamin Lichtbroun, Saum Ghodoussipour, et al.
Pageof 14